FormDSignal
60

Sparrow Pharmaceuticals, Inc. raises $61.8M under Reg D

Company raise · Raising · PORTLAND, OR · Form D filed 2025-07-01
$50M+ raiseFirst raise on EDGAR

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Jonathan RootDirector
Niall O'DonnellDirector
Zach ScheinerDirector
Klaus VeitingerDirector
Nanna L?neborgDirector
Peter ThompsonDirector
Robert JacksExecutive Officer, Director

Signed by Robert Jacks, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.